Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2020 May;40(5):781-789.
doi: 10.1038/s41372-020-0614-4. Epub 2020 Feb 17.

Medications and in-hospital outcomes in infants born at 22-24 weeks of gestation

Mihai Puia-Dumitrescu  1   2 , Noelle Younge  2 , Daniel K Benjamin  3 , Katie Lawson  4 , Cordelia Hume  4 , Kennedy Hill  4 , Jonathan Mengistu  4 , Aryeona Wilson  4 , Kanecia O Zimmerman  2   4 , Kaashif Ahmad  5 , Rachel G Greenberg  6   7
Affiliations
Multicenter Study

Medications and in-hospital outcomes in infants born at 22-24 weeks of gestation

Mihai Puia-Dumitrescu et al. J Perinatol. 2020 May.

Abstract

Objective: To evaluate the most commonly used medications and in-hospital morbidities and mortality in infants born 22-24 weeks of gestation.

Study design: Multicenter retrospective cohort study of infants born 22-24 weeks of gestation (2006-2016), without major congenital anomalies and with available medication data obtained from neonatal intensive care units managed by the Pediatrix Medical Group.

Results: This study included 7578 infants from 195 sites. Median (25th, 75th percentile): birthweight was 610 g (540, 680); the number of distinct medications used was 13 (8, 18); and different antimicrobial exposure was 4 (2, 5). The most common morbidities were BPD (41%) and grade III or IV IVH (20%), and overall survival varied from 46% (2006) to 57% (2016).

Conclusions: A large number of medications were used in periviable infants. There was a high prevalence of in-hospital morbidities, and survival of this population increased over the study period.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest NY received support from the NIH (K23DK12 0960). MP-D, DKB, KL, CH, KH, JM, AW, KOZ, KA, and RGG report no relevant disclosures.

Figures

Fig. 1
Fig. 1. Number of medications and survival by site.
a medication use across sites: distribution of the median number of medications to which a periviable infant was exposed during the study period; and b survival among sites with >20 infants: distribution of the proportion of infants 22–24 weeks GA who survived to discharge. GA gestational age.
Fig. 2
Fig. 2. Survival by GA.
Survival rates among infants born at 22–24 weeks GA, from 2006 to 2016. GA gestational age.
See this image and copyright information in PMC

References

    1. Ecker JL, Kaimal A, Mercer BM, Blackwell SC, deRegnier RA. American College of Obstetricians and Gynecologists and the Society for Maternal–Fetal Medicine, et al. Periviable birth: interim update. Am J Obstet Gynecol. 2016;215:B2–B12.e1. - PubMed
    1. Raju TN, Mercer BM, Burchfield DJ, Joseph GF. Periviable birth: executive summary of a joint workshop by the Eunice Kennedy Shriver National Institute of Child Health and Human Development, Society for Maternal-Fetal Medicine, American Academy of Pediatrics, and American College of Obstetricians and Gynecologists. J Perinatol. 2014;34:333–42. - PubMed
    1. Mercer BM. Periviable birth and the shifting limit of biability. Clin Perinatol. 2017;44:283–6. - PubMed
    1. Brumbaugh JE, Hansen NI, Bell EF, Sridhar A, Carlo WA, Hintz SR, et al. Outcomes of extremely preterm infants with birth weight less than 400 g. JAMA Pediatr. 2019;173:434–45. - PMC - PubMed
    1. Stoll BJ, Hansen NI, Bell EF, Shankaran S, Laptook AR, Walsh MC, et al. Neonatal outcomes of extremely preterm infants from the NICHD Neonatal Research Network. Pediatrics. 2010;126:443–56. - PMC - PubMed

Publication types